Early growth response genes signaling supports strong paracrine capability of mesenchymal stem cells

Stem Cells International

Volumn , Issue , 2012, Pages

  Tamama, Kenichi ^a   Barbeau, Dominique J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CYCLOOXYGENASE 2; EARLY GROWTH RESPONSE FACTOR; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 2; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; SCATTER FACTOR; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

AUTOCRINE EFFECT; CELL EXPANSION; CELL THERAPY; DOWN REGULATION; EARLY GROWTH RESPONSE GENE; EXOSOME; FIBROSIS; GENE; HUMAN; HYPOXIA; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; ISCHEMIA; MESENCHYMAL STEM CELL; MOLECULAR MECHANICS; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; UPREGULATION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 84871833427     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2012/428403     Document Type: Review

References (89)

1. Friedenstein A. J., Gorskaja U. F., Kulagina N. N., Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Experimental Hematology 1976 4 5 267 274 2-s2.0-0017119380
2. Oswald J., Boxberger S., Jørgensen B., Feldmann S., Ehninger G., Bornhäuser M., Werner C., Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004 22 3 377 384 2-s2.0-2942523981 (Pubitemid 38736621)
3. Pittenger M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., Moorman M. A., Simonetti D. W., Craig S., Marshak D. R., Multilineage potential of adult human mesenchymal stem cells. Science 1999 284 5411 143 147 2-s2.0-0033515827 10.1126/science.284.5411.143 (Pubitemid 29282067)
4. Prockop D. J., Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997 276 5309 71 74 2-s2.0-0030889354 10.1126/science.276.5309. 71 (Pubitemid 27161245)
5. Prockop D. J., Gregory C. A., Spees J. L., One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proceedings of the National Academy of Sciences of the United States of America 2003 100 1 11917 11923 2-s2.0-0141483047 10.1073/pnas.1834138100 (Pubitemid 37205904)
6. Tamama K., Fan V. H., Griffith L. G., Blair H. C., Wells A., Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 2006 24 3 686 695 2-s2.0-33744979059 10.1634/stemcells.2005-0176 (Pubitemid 44464773)
7. Tamama K., Sen C. K., Wells A., Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells and Development 2008 17 5 897 908 2-s2.0-58149145667 10.1089/scd.2007.0155
8. Kinnaird T., Stabile E., Burnett M. S., Epstein S. E., Bone marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circulation Research 2004 95 4 354 363 2-s2.0-4143128861 10.1161/01.RES.0000137878.26174.66 (Pubitemid 39100453)
9. Davani S., Marandin A., Mersin N., Royer B., Kantelip B., Hervé P., Etievent J. P., Kantelip J. P., Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 2003 108 supplement 1 II253 II258 2-s2.0-0042416929 (Pubitemid 37099964)
10. Amado L. C., Saliaris A. P., Schuleri K. H., John M. S., Xie J. S., Cattaneo S., Durand D. J., Fitton T., Kuang J. Q., Stewart G., Lehrke S., Baumgartner W. W., Martin B. J., Heldman A. W., Hare J. M., Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America 2005 102 32 11474 11479 2-s2.0-23844475067 10.1073/pnas.0504388102 (Pubitemid 41153844)
11. Dai W., Hale S. L., Martin B. J., Kuang J. Q., Dow J. S., Wold L. E., Kloner R. A., Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005 112 2 214 223 2-s2.0-22144475112 10.1161/CIRCULATIONAHA.104.527937 (Pubitemid 40982304)
12. Pittenger M. F., Martin B. J., Mesenchymal stem cells and their potential as cardiac therapeutics. Circulation Research 2004 95 1 9 20 2-s2.0-3142663241 10.1161/01.RES.0000135902.99383.6f (Pubitemid 38931831)
13. Wu Y., Chen L., Scott P. G., Tredget E. E., Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007 25 10 2648 2659 2-s2.0-35348831024 10.1634/stemcells.2007-0226 (Pubitemid 47582758)
14. Sasaki M., Abe R., Fujita Y., Ando S., Inokuma D., Shimizu H., Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. Journal of Immunology 2008 180 4 2581 2587 2-s2.0-42149189474
15. Uccelli A., Moretta L., Pistoia V., Mesenchymal stem cells in health and disease. Nature Reviews Immunology 2008 8 9 726 736 2-s2.0-50249158511 10.1038/nri2395
16. Mangi A. A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J. S., Dzau V. J., Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nature Medicine 2003 9 9 1195 1201 2-s2.0-0141796313 10.1038/nm912 (Pubitemid 37173705)
17. Giordano A., Galderisi U., Marino I. R., From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. Journal of Cellular Physiology 2007 211 1 27 35 2-s2.0-33847617021 10.1002/jcp.20959 (Pubitemid 46363893)
18. Schuleri K. H., Boyle A. J., Hare J. M., Mesenchymal stem cells for cardiac regenerative therapy. Handbook of experimental pharmacology 2007 180 195 218 2-s2.0-34547579296
19. Falanga V., Iwamoto S., Chartier M., Yufit T., Butmarc J., Kouttab N., Shrayer D., Carson P., Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Engineering 2007 13 6 1299 1312 2-s2.0-34250883216 10.1089/ten.2006.0278 (Pubitemid 46986730)
20. Tongers J., Losordo D. W., Landmesser U., Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. European Heart Journal 2011 32 10 1197 1206 2-s2.0-79955512050 10.1093/eurheartj/ehr018
21. Chen L., Tredget E. E., Wu P. Y. G., Wu Y., Wu Y., Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 2008 3 4 2-s2.0-44849121129 10.1371/journal. pone.0001886 e1886 (Pubitemid 351943822)
22. Schinköthe T., Bloch W., Schmidt A., In vitro secreting profile of human mesenchymal stem cells. Stem Cells and Development 2008 17 1 199 206
23. Shimada I. S., Spees J. L., Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics. Journal of Cellular Biochemistry 2011 112 2 374 380 2-s2.0-79251623313 10.1002/jcb.22963
24. Crisan M., Yap S., Casteilla L., Chen C. W., Corselli M., Park T. S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P. N., Traas J., Schugar R., Deasy B. M., Badylak S., Buhring H. J., Giacobino J. P., Lazzari L., Huard J., Péault B., A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008 3 3 301 313 2-s2.0-50849139576 10.1016/j.stem.2008.07.003
25. Kerpedjieva S. S., Kim D. S., Barbeau D. J., Tamama K., EGFR ligands drive multipotential stromal cells to produce multiple growth factors and cytokines via early growth response-1. Stem Cells and Development 2012 21 13 2541 2551
26. Tamama K., Kawasaki H., Wells A., Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. Journal of biomedicine & biotechnology 2010 2010 795385 2-s2.0-77953158654
27. Agata H., Watanabe N., Ishii Y., Kubo N., Ohshima S., Yamazaki M., Tojo A., Kagami H., Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions. Biochemical and Biophysical Research Communications 2009 382 2 353 358 2-s2.0-63349088557 10.1016/j.bbrc.2009.03.023
28. Ng F., Boucher S., Koh S., Sastry K. S. R., Chase L., Lakshmipathy U., Choong C., Yang Z., Vemuri M. C., Rao M. S., Tanavde V., PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 2008 112 2 295 307
29. Sensebé L., Krampera M., Schrezenmeier H., Bourin P., Giordano R., Mesenchymal stem cells for clinical application. Vox Sanguinis 2010 98 2 93 107 2-s2.0-74549219852 10.1111/j.1423-0410.2009.01227.x
30. Fan V. H., Tamama K., Au A., Littrell R., Richardson L. B., Wright J. W., Wells A., Griffith L. G., Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 2007 25 5 1241 1251 2-s2.0-34247638937 10.1634/stemcells.2006-0320 (Pubitemid 46684884)
31. Wells A., EGF receptor. International Journal of Biochemistry and Cell Biology 1999 31 6 637 643 2-s2.0-0032999409 10.1016/S1357-2725(99)00015-1 (Pubitemid 29248872)
32. Caplan A. I., Why are MSCs therapeutic? New data: new insight. Journal of Pathology 2009 217 2 318 324 2-s2.0-58449135981 10.1002/path.2469
33. Silverman E. S., Collins T., Pathways of Egr-1-mediated gene transcription in vascular biology. American Journal of Pathology 1999 154 3 665 670 2-s2.0-0033000998 (Pubitemid 29122584)
34. Thiel G., Cibelli G., Regulation of life and death by the zinc finger transcription factor Egr-1. Journal of Cellular Physiology 2002 193 3 287 292 2-s2.0-0036888651 10.1002/jcp.10178 (Pubitemid 35265949)
35. Christy B., Nathans D., DNA binding site of the growth factor-inducible protein Zif268. Proceedings of the National Academy of Sciences of the United States of America 1989 86 22 8737 8741 2-s2.0-0024391088 10.1073/pnas.86.22.8737 (Pubitemid 20010299)
36. Fang F., Ooka K., Bhattachyya S., Wei J., Wu M., Du P., Lin S., Del Galdo F., Feghali-Bostwick C. A., Varga J., The early growth response gene Egr2 (alias Krox20) is a novel transcriptional target of transforming growth factor- β that is up-regulated in systemic sclerosis and mediates profibrotic responses. American Journal of Pathology 2011 178 5 2077 2090 2-s2.0-79958167861 10.1016/j.ajpath.2011.01.035
37. Le N., Nagarajan R., Wang J. Y. T., Araki T., Schmidt R. E., Milbrandt J., Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proceedings of the National Academy of Sciences of the United States of America 2005 102 7 2596 2601 2-s2.0-14044266360 10.1073/pnas.0407836102 (Pubitemid 40279422)
38. Lee S. L., Sadovsky Y., Swirnoff A. H., Polish J. A., Goda P., Gavrilina G., Milbrandt J., Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 1996 273 5279 1219 1221 2-s2.0-0029812609 (Pubitemid 26293210)
39. Suehiro J. I., Hamakubo T., Kodama T., Aird W. C., Minami T., Vascular endothelial growth factor activation of endothelial cells is mediated by early growth response-3. Blood 2010 115 12 2520 2532 2-s2.0-77950603795 10.1182/blood-2009-07-233478
40. Khachigian L. M., Early growth response-1 in cardiovascular pathobiology. Circulation Research 2006 98 2 186 191 2-s2.0-33644850380 10.1161/01.RES. 0000200177.53882.c3
41. Adamson E. D., Mercola D., Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival. Tumor Biology 2002 23 2 93 102 2-s2.0-0036270508 10.1159/000059711 (Pubitemid 34639111)
42. Street V. A., Bennett C. L., Goldy J. D., Shirk A. J., Kleopa K. A., Tempel B. L., Lipe H. P., Scherer S. S., Bird T. D., Chance P. F., Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003 60 1 22 26 2-s2.0-0037435540 (Pubitemid 36070638)
43. Warner L. E., Mancias P., Butler I. J., McDonald C. M., Keppen L., Koob K. G., Lupski J. R., Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nature Genetics 1998 18 4 382 384 2-s2.0-0031943222 10.1038/ng0498-382 (Pubitemid 28158170)
44. Safford M., Collins S., Lutz M. A., Allen A., Huang C. T., Kowalski J., Blackford A., Horton M. R., Drake C., Schwartz R. H., Powell J. D., Egr-2 and Egr-3 are negative regulators of T cell activation. Nature Immunology 2005 6 5 472 480 2-s2.0-18244375249 10.1038/ni1193 (Pubitemid 41716760)
45. Tourtellotte W. G., Milbrandt J., Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. Nature Genetics 1998 20 1 87 91 2-s2.0-0031710559 10.1038/1757 (Pubitemid 28410352)
46. Bonner J. C., Regulation of PDGF and its receptors in fibrotic diseases. Cytokine and Growth Factor Reviews 2004 15 4 255 273 2-s2.0-2942682928 10.1016/j.cytogfr.2004.03.006 (Pubitemid 38781050)
47. Leask A., Potential therapeutic targets for cardiac fibrosis: TGF β angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circulation Research 2010 106 11 1675 1680 2-s2.0-77953808712 10.1161/CIRCRESAHA.110.217737
48. Barrientos S., Stojadinovic O., Golinko M. S., Brem H., Tomic-Canic M., Growth factors and cytokines in wound healing. Wound Repair and Regeneration 2008 16 5 585 601 2-s2.0-51349167276 10.1111/j.1524-475X.2008.00410.x
49. Beyer C., Distler J. H., Distler O., Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases? Swiss Medical Weekly 2010 140 w13050 2-s2.0-79952053396
50. Chen J., Chen J. K., Nagai K., Plieth D., Tan M., Lee T. C., Threadgill D. W., Neilson E. G., Harris R. C., EGFR signaling promotes TGFbeta-dependent renal fibrosis. Journal of the American Society of Nephrology 2012 23 2 215 224
51. Ingram J. L., Bonner J. C., EGF and PDGF receptor tyrosine kinases as therapeutic targets for chronic lung diseases. Current Molecular Medicine 2006 6 4 409 421 2-s2.0-33744783176 10.2174/156652406777435426 (Pubitemid 43834254)
52. Bhattacharyya S., Sargent J. L., Du P., Lin S., Tourtellotte W. G., Takehara K., Whitfield M. L., Varga J., Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis. PLoS ONE 2011 6 9 e23082
53. Kumbrink J., Kirsch K. H., Johnson J. P., EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin. Journal of Cellular Biochemistry 2010 111 1 207 217 2-s2.0-77957174189 10.1002/jcb.22690
54. Feingold E. A., Good P. J., Guyer M. S., Kamholz S., Liefer L., Wetterstrand K., Collins F. S., Gingeras T. R., Kampa D., Sekinger E. A., Cheng J., Hirsch H., Ghosh S., Zhu Z., Patel S., Piccolboni A., Yang A., Tammana H., Bekiranov S., Kapranov P., Harrison R., Church G., Struhl K., Ren B., Kim T. H., Barrera L. O., Qu C., van Calcar S., Luna R., Glass C. K., Rosenfeld M. G., Guigo R., Antonarakis S. E., Birney E., Brent M., Pachter L., Reymond A., Dermitzakis E. T., Dewey C., Keefe D., Denoeud F., Lagarde J., Ashurst J., Hubbard T., Wesselink J. J., Castelo R., Eyras E., Myers R. M., Sidow A., Batzoglou S., Trinklein N. D., Hartman S. J., Aldred S. F., Anton E., Schroeder D. I., Marticke S. S., Nguyen L., Schmutz J., Grimwood J., Dickson M., Cooper G. M., Stone E. A., Asimenos G., Brudno M., Dutta A., Karnani N., Taylor C. M., Kim H. K., Robins G., Stamatoyannopoulos G., Stamatoyannopoulos J. A., Dorschner M., Sabo P., Hawrylycz M., Humbert R., Wallace J., Yu M., Navas P. A., McArthur M., Noble W. S., Dunham I., Koch C. M., Andrews R. M., Clelland G. K., Wilcox S., Fowler J. C., James K. D., Groth P., Dovey O. M., Ellis P. D., Wraight V. L., Mungall A. J., Dhami P., Fiegler H., Langford C. F., Carter N. P., Vetrie D., Snyder M., Euskirchen G., Urban A. E., Nagalakshmi U., Rinn J., Popescu G., Bertone P., Hartman S., Rozowsky J., Emanuelsson O., Royce T., Chung S., Gerstein M., Lian Z., Lian J., Nakayama Y., Weissman S., Stolc V., Tongprasit W., Sethi H., Jones S., Marra M., Shin H., Schein J., Clamp M., Lindblad-Toh K., Chang J., Jaffe D. B., Kamal M., Lander E. S., Mikkelsen T. S., Vinson J., Zody M. C., de Jong P. J., Osoegawa K., Nefedov M., Zhu B., Baxevanis A. D., Wolfsberg T. G., Crawford G. E., Whittle J., Holt I. E., Vasicek T. J., Zhou D., Luo S., Green E. D., Bouffard G. G., Margulies E. H., Portnoy M. E., Hansen N. F., Thomas P. J., McDowell J. C., Maskeri B., Young A. C., Idol J. R., Blakesley R. W., Schuler G., Miller W., Hardison R., Elnitski L., Shah P., Salzberg S. L., Pertea M., Majoros W. H., Haussler D., Thomas D., Rosenbloom K. R., Clawson H., Siepel A., Kent W. J., Weng Z., Jin S., Halees A., Burden H., Karaoz U., Fu Y., Yu Y., Ding C., Cantor C. R., Kingston R. E., Dennis J., Green R. D., Singer M. A., Richmond T. A., Norton J. E., Farnham P. J., Oberley M. J., Inman D. R., McCormick M. R., Kim H., Middle C. L., Pirrung M. C., Fu X. D., Kwon Y. S., Ye Z., Dekker J., Tabuchi T. M., Gheldof N., Dostie J., Harvey S. C., The ENCODE (ENCyclopedia of DNA Elements) Project. Science 2004 306 5696 636 640 10.1126/science.1105136 (Pubitemid 39440902)
55. Feingold E. A., Good P. J., Guyer M. S., A user's guide to the encyclopedia of DNA elements (encode). PLoS Biology 2011 9 4 2-s2.0-79955550445 10.1371/journal.pbio.1001046 e1001046
56. Rosenbloom K. R., Dreszer T. R., Long J. C., ENCODE whole-genome data in the UCSC Genome Browser: update 2012. Nucleic Acids Research 2012 40 D912 D917
57. Meyer L. R., Zweig A. S., Hinrichs A. S., The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Research. In press
58. Gurtner G. C., Werner S., Barrandon Y., Longaker M. T., Wound repair and regeneration. Nature 2008 453 7193 314 321 2-s2.0-43749088730 10.1038/nature07039 (Pubitemid 351693137)
59. Martin P., Wound healing-aiming for perfect skin regeneration. Science 1997 276 5309 75 81 2-s2.0-0030934532 10.1126/science.276.5309.75 (Pubitemid 27161246)
60. Sen C. K., Wound healing essentials: let there be oxygen. Wound Repair and Regeneration 2009 17 1 1 18 2-s2.0-58649103319 10.1111/j.1524-475X.2008. 00436.x
61. Dvorak H. F., Angiogenesis: update 2005. Journal of Thrombosis and Haemostasis 2005 3 8 1835 1842 2-s2.0-27944442568 10.1111/j.1538-7836.2005. 01361.x (Pubitemid 41716570)
62. Tamama K., Kerpedjieva S. S., Acceleration of wound healing by multiple growth factors and cytokines secreted from multipotential stromal cells/mesenchymal stem cells (MSCs). Advances in Wound Care 2012 1 4 177 182
63. Simon M. C., Keith B., The role of oxygen availability in embryonic development and stem cell function. Nature Reviews Molecular Cell Biology 2008 9 4 285 296 2-s2.0-41149115123 10.1038/nrm2354 (Pubitemid 351430845)
64. Tian H., McKnight S. L., Russell D. W., Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes and Development 1997 11 1 72 82 2-s2.0-0031020884 (Pubitemid 27043825)
65. Wiesener M. S., Jürgensen J. S., Rosenberger C., Scholze C. K., Hörstrup J. H., Warnecke C., Mandriota S., Bechmann I., Frei U. A., Pugh C. W., Ratcliffe P. J., Bachmann S., Maxwell P. H., Eckardt K. U., Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. The FASEB Journal 2003 17 2 271 273 2-s2.0-0037315337
66. Tamama K., Kawasaki H., Kerpedjieva S. S., Guan J., Ganju R. K., Sen C. K., Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition. Journal of Cellular Biochemistry 2011 112 3 804 817 2-s2.0-79951802302 10.1002/jcb.22961
67. Tamama K., Kim D., Kerpedjieva S. S., Vordermark D., Molecular mechanisms of hypoxia-mediated enhanced in vitro expansion, augmented self-renewal, and increased therapeutic potential of mesenchymal stem cells. Hypoxia: Causes, Types and Management Hauppauge, NY, USA Nova Science
68. Crisostomo P. R., Wang Y., Markel T. A., Wang M., Lahm T., Meldrum D. R., Human mesenchymal stem cells stimulated by TNF- α LPS, or hypoxia produce growth factors by an NF B- but not JNK-dependent mechanism. American Journal of Physiology 2008 294 3 C675 C682 2-s2.0-41549105367 10.1152/ajpcell.00437.2007 (Pubitemid 351468685)
69. Das R., Jahr H., van Osch G. J., Farrell E., The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue engineering B 2010 16 2 159 168 2-s2.0-77953630542 10.1089/ten.teb.2009.0296
70. Mylotte L. A., Duffy A. M., Murphy M., O'Brien T., Samali A., Barry F., Szegezdi E., Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells 2008 26 5 1325 1336 2-s2.0-47949101704 10.1634/stemcells.2007-1072
71. Okuyama H., Krishnamachary B., Zhou Y. F., Nagasawa H., Bosch-Marce M., Semenza G. L., Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. The Journal of Biological Chemistry 2006 281 22 15554 15563 2-s2.0-33744959141 10.1074/jbc.M602003200 (Pubitemid 43855148)
72. Rosová I., Dao M., Capoccia B., Link D., Nolta J. A., Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008 26 8 2173 2182 2-s2.0-55049084643 10.1634/stemcells.2007-1104
73. Song S. W., Chang W., Song B. W., Song H., Lim S., Kim H. J., Cha M. J., Choi E., Im S. H., Chang B. C., Chung N., Jang Y., Hwang K. C., Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem Cells 2009 27 6 1358 1365 2-s2.0-67649628227 10.1002/stem.47
74. Xu R., Chen J., Cong X., Hu S., Chen X., Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2. Journal of Cellular Biochemistry 2008 103 1 256 269 2-s2.0-38149111737 10.1002/jcb.21402
75. Zhu W., Chen J., Cong X., Hu S., Chen X., Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 2006 24 2 416 425 2-s2.0-33745954928 10.1634/stemcells.2005-0121
76. Rong Y., Hu F., Huang R., Mackman N., Horowitz J. M., Jensen R. L., Durden D. L., Van Meir E. G., Brat D. J., Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Research 2006 66 14 7067 7074 2-s2.0-33746925159 10.1158/0008-5472.CAN-06-0346 (Pubitemid 44197683)
77. Yan S. F., Lu J., Zou Y. S., Soh-Won J., Cohen D. M., Buttrick P. M., Cooper D. R., Steinberg S. F., Mackman N., Pinsky D. J., Stern D. M., Hypoxia-associated induction of early growth response-1 gene expression. The Journal of Biological Chemistry 1999 274 21 15030 15040 2-s2.0-0033591346 10.1074/jbc.274.21.15030 (Pubitemid 29265890)
78. Pierce G. F., Inflammation in nonhealing diabetic wounds: the space-time continuum does matter. American Journal of Pathology 2001 159 2 399 403 2-s2.0-0034889301 (Pubitemid 32751068)
79. Schaffer M., Witte M., Becker H. D., Models to study ischemia in chronic wounds. The International Journal of Lower Extremity Wounds 2002 1 2 104 111
80. Willenborg S., Knipper J., Ranjan R., Krieg T., Eming S. A., Sen C. K., Chronic Wounds and Inflammation. Wound Healing Society Year Book (WHSYB)-Advances in Wound Care 2010 New Rochelle, NY, USA Mary Ann Liebert
81. Wu M., Melichian D. S., De La Garza M., Gruner K., Bhattacharyya S., Barr L., Nair A., Shahrara S., Sporn P. H. S., Mustoe T. A., Tourtellotte W. G., Varga J., Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing. American Journal of Pathology 2009 175 3 1041 1055 2-s2.0-70349237004 10.2353/ajpath.2009.090241
82. Février B., Raposo G., Exosomes: Endosomal-derived vesicles shipping extracellular messages. Current Opinion in Cell Biology 2004 16 4 415 421 2-s2.0-3142630225 10.1016/j.ceb.2004.06.003 (Pubitemid 38903148)
83. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J. J., Lötvall J. O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007 9 6 654 659 2-s2.0-34249302620 10.1038/ncb1596 (Pubitemid 47214727)
84. Yeo R. W., Lai R. C., Zhang B., Tan S. S., Yin Y., Teh B. J., Lim S. K., Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Advanced Drug Delivery Reviews. In press
85. Lai R. C., Chen T. S., Lim S. K., Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regenerative Medicine 2011 6 4 481 492 2-s2.0-79960223740 10.2217/rme.11.35
86. Bruno S., Grange C., Deregibus M. C., Calogero R. A., Saviozzi S., Collino F., Morando L., Busca A., Falda M., Bussolati B., Tetta C., Camussi G., Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. Journal of the American Society of Nephrology 2009 20 5 1053 1067 2-s2.0-65649089130 10.1681/ASN.2008070798
87. Collino F., Deregibus M. C., Bruno S., Sterpone L., Aghemo G., Viltono L., Tetta C., Camussi G., Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 2010 5 7 2-s2.0-77955643809 10.1371/journal.pone.0011803 e11803
88. Lai R. C., Arslan F., Lee M. M., Sze N. S. K., Choo A., Chen T. S., Salto-Tellez M., Timmers L., Lee C. N., El Oakley R. M., Pasterkamp G., de Kleijn D. P. V., Lim S. K., Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research 2010 4 3 214 222 2-s2.0-77952293014 10.1016/j.scr.2009.12.003
89. Tomasoni S., Longaretti L., Rota C., Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells and Development. In press